Progressive Care, Inc. Announces Executive Changes
December 22, 2021 at 07:00 am EST
Share
Progressive Care Inc. announced that the Company has appointed Birute Norkute and Joseph Ziegler to join the Companys Board of Directors. Mr. Ziegler is currently the Chief Financial Officer of DAS Health. Mr. Ziegler previously served as CFO for Encompass Onsite, where he led a team through a period of rapid growth driven by acquisitions and new customer onboarding while improving the financial infrastructure of the business. Prior to joining Encompass, he held multiple roles as a CFO in the healthcare industry, including Private Equity backed specialty pharmacy Biomatrix, successfully driving top-line growth from $60 million to $500 million during his tenure with the company. Prior to serving as CFO of Biomatrix, Mr. Ziegler served as CFO of Novis Pharmaceuticals, driving the companys growth from $60 million to $200 million during his tenure and led the companys sales process to strategic acquirer Cardinal Health. He graduated from Florida Atlantic University with an MBA following a BS in finance. Ms. Norkute has been a key part of Progressive Care and its/our pharmacy operations team since 2008 and has been leading the Companys operations since 2013. She stands out as the driving force behind a number of critical accomplishments. As the chief architect of the operational model for ensuring medication adherence, her work is reflected in the Companys consistent 5-star performance ratings in pharmacy dispensing and medication therapy management. Before ascending to her current role as COO, Birute controlled budgetary compliance for PharmCoRx locations leading to efficiencies that were often superior to those of automated systems. She also has strong experience managing the Companys IT infrastructure to ensure current protocols are in place for HIPAA compliance and technological efficiency.
Progressive Care, Inc. is a personalized healthcare services and technology provider. The Company operates through two segments: Pharmacy Operations and Third-Party Administration. The Pharmacy Operations segment provides prescription pharmaceuticals, compounded medications, tele-pharmacy services, COVID-19 related diagnostics and vaccinations, anti-retroviral medications, medication therapy management, the supply of prescription medications to long-term care facilities, medication adherence packaging, and contracted pharmacy services for 340B covered entities under the 340B Drug Discount Pricing Program. The Third-Party Administration segment provides data management and reporting services to support health care organizations. It offers services in a variety of languages, including English, Spanish, French, Creole, Portuguese, Ukrainian and Russian. Through its wholly owned subsidiary, ClearMetrX, it offers data management and reporting services to support health care organizations.